Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era
The clinical outcome of patients with human epidermal growth factor receptor 2 (HER2) amplified breast carcinoma (BC) has improved with the development of anti-HER2 targeted therapies. However, patients can experience disease recurrence after curative intent and disease progression in the metastatic...
Shranjeno v:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2021-12-01
|
| Serija: | Breast |
| Teme: | |
| Online dostop: | http://www.sciencedirect.com/science/article/pii/S0960977621004379 |
| Oznake: |
Brez oznak, prvi označite!
|